Den europeiske union - islandsk - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Den europeiske union - islandsk - EMA (European Medicines Agency)

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - Æxlishemjandi lyf - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

aco hud nordic ab* - ferrosi sulfas - forðatafla - 100 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - bicalutamidum inn - filmuhúðuð tafla - 150 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - bicalutamidum inn - filmuhúðuð tafla - 50 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - desloratadinum inn - munndreifitafla - 5 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - letrozolum inn - filmuhúðuð tafla - 2,5 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - letrozolum inn - filmuhúðuð tafla - 2,5 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - simvastatinum inn - filmuhúðuð tafla - 20 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - simvastatinum inn - filmuhúðuð tafla - 40 mg